BPH Energy Limited (BPH.AX)
- Previous Close
0.0200 - Open
0.0200 - Bid 0.0200 x --
- Ask 0.0200 x --
- Day's Range
0.0200 - 0.0210 - 52 Week Range
0.0170 - 0.0710 - Volume
223,994 - Avg. Volume
4,593,987 - Market Cap (intraday)
22.951M - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date Jul 11, 2024 - Jul 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BPH Energy Limited invests in biotechnology, oil and gas exploration and development, and medicinal cannabis industries in Australia. The company is building a system to generate clean hydrogen and conductive carbon used to manufacture batteries for commercial use. It also offers brain anaesthesia response monitoring system, a device to detect the effect of anaesthetic agents on brain activity and assist anaesthetists in keeping patients optimally anaesthetised. In addition, the company invests in the biomedical research of HLS5 tumour suppressor gene for liver cancer. Further, it holds a 100% interest in RL1 oil and gas assets located in the onshore Bonaparte basin in northern Australia; and 85% interest in the petroleum exploration permit 11 situated in the offshore Sydney basin. The company was formerly known as BioPharmica Limited. BPH Energy Limited was incorporated in 2001 and is headquartered in Stirling, Australia.
www.bphenergy.com.auRecent News: BPH.AX
Performance Overview: BPH.AX
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BPH.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BPH.AX
Valuation Measures
Market Cap
22.95M
Enterprise Value
16.06M
Trailing P/E
16.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.10
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
19.32
Financial Highlights
Profitability and Income Statement
Profit Margin
258.82%
Return on Assets (ttm)
-4.07%
Return on Equity (ttm)
4.82%
Revenue (ttm)
345.67k
Net Income Avi to Common (ttm)
894.65k
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
5.13M
Total Debt/Equity (mrq)
0.43%
Levered Free Cash Flow (ttm)
-2.14M